Propanc Biopharma, Inc. SEC filings PPCB
Propanc Biopharma, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jun 23, 2011. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (listing notice). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 29, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 26, 2026 | Feb 20, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 7, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Nov 10, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 14, 2025 | Oct 7, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Aug 19, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 30, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 22, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 27, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 18, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 2, 2025 | May 7, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 8, 2025 | May 7, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 21, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 18, 2025 | Mar 14, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 12, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 20, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 6, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 27, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 30, 2024 | Aug 26, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 15, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 7, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 2, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 21, 2024 | Jun 17, 2024 |
| 8-K/A |
Amended current report
Material agreement, New debt, Unregistered share sale
|
Jun 13, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 12, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 5, 2024 | May 31, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
May 16, 2024 | May 10, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 22, 2024 | Apr 16, 2024 |
| 8-K |
Current report
Other events
|
Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 11, 2024 | Mar 5, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 15, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 7, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Other events
|
Oct 30, 2023 | Oct 29, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 26, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 17, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 29, 2023 | Aug 29, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 21, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 26, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 12, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
May 5, 2023 | May 5, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 17, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Other events
|
Feb 22, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 21, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2022 | Oct 26, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 12, 2022 | Oct 6, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 27, 2022 | Sep 21, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 18, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 11, 2022 | Jul 6, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 7, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 18, 2022 | May 12, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 18, 2022 | Apr 12, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 1, 2022 | Mar 29, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 10, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 10, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 13, 2021 | Dec 7, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 7, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 1, 2021 | Nov 26, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 27, 2021 | Oct 21, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 28, 2021 | Sep 22, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 25, 2021 | Aug 19, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Aug 18, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 19, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 11, 2021 | Jan 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2020 | Dec 23, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 16, 2020 | Dec 10, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 7, 2020 | Dec 2, 2020 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Nov 19, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 3, 2020 | Mar 30, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 17, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 8, 2019 | Oct 2, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 9, 2019 | Sep 3, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 6, 2019 | Jul 31, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 10, 2019 | Jul 3, 2019 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Jul 1, 2019 | Jun 24, 2019 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 21, 2019 | Jun 21, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 30, 2019 | May 23, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
May 15, 2019 | May 14, 2019 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale
|
Feb 25, 2019 | Feb 25, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 12, 2019 | Feb 12, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 28, 2018 | Dec 24, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 6, 2018 | Nov 30, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 10, 2018 | Oct 5, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 5, 2018 | Oct 2, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 27, 2018 | Sep 21, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 7, 2018 | Sep 7, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 4, 2018 | Aug 28, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 19, 2018 | Jul 13, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 6, 2018 | Jun 29, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 2, 2018 | Jun 26, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 20, 2018 | Jun 14, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 19, 2018 | Apr 13, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2018 | Apr 10, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 29, 2018 | Mar 23, 2018 |
| 8-K |
Current report
Officer or director change
|
Mar 22, 2018 | Mar 16, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 14, 2018 | Mar 14, 2018 |
| 8-K |
Current report
Other events
|
Feb 20, 2018 | Feb 20, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
|
Jan 26, 2018 | Jan 22, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 5, 2018 | Dec 29, 2017 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 2, 2017 | Sep 30, 2017 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 15, 2017 | Aug 9, 2017 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 28, 2017 | Jul 24, 2017 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Jun 1, 2017 | May 26, 2017 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 26, 2017 | Apr 20, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 5, 2017 | Apr 4, 2017 |
| 8-K |
Current report
Other events
|
Mar 31, 2017 | Mar 31, 2017 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 21, 2017 | Mar 17, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Feb 23, 2017 | Feb 16, 2017 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 3, 2017 | Jan 27, 2017 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Dec 30, 2016 | Dec 23, 2016 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 7, 2016 | Dec 1, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 23, 2016 | Nov 18, 2016 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 16, 2016 | Sep 15, 2016 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 23, 2016 | Aug 22, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 4, 2016 | Aug 3, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 5, 2016 | Jul 1, 2016 |
| 8-K |
Current report
Other events
|
May 24, 2016 | May 20, 2016 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 11, 2016 | Mar 11, 2016 |
| 8-K |
Current report
Other events
|
Nov 17, 2015 | Nov 17, 2015 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Nov 3, 2015 | Oct 28, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 29, 2015 | Sep 24, 2015 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Jul 15, 2015 | Jun 16, 2014 |
| 8-K |
Current report
Other events
|
Jun 18, 2015 | May 1, 2015 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 13, 2015 | Jan 27, 2015 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Dec 16, 2014 | Nov 12, 2014 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 22, 2014 | May 29, 2014 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2012 | Aug 5, 2012 |
| 8-K |
Current report
Other events
|
Jun 27, 2012 | Jun 27, 2012 |
Showing 131 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PPCB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Camberwell, Victoria, Australia
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1517681
- Former names
- Propanc Health Group Corp (until Apr 5, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.